Literature DB >> 123293

Congenital and acquired abnormalities observed in live-born and stillborn neonates.

L E Harris, L A Stayura, P F Ramirez-Talavera, J F Annegers.   

Abstract

This report records the congenital and acquired abnormalities observed during the first 4 days of life in 21,142 live-born infants. Gross abnormalities observed in 300 stillborns also are recorded. The abnormalities are those thought to be of clinical or possibly clinical significance. Also included are other conditions ordinarily not considered to be a congenital abnormality, such as convulsions. Definitions are given when indicated. The incidence rates per 1,000 births for specific malformation noted in the first 4 days of life are provided for all births, for live births, for live births under 2,500 g, and for stillbirths. The need for accurate studies of specific forms of congenital malformations is reiterated. The rate for all malformations combined is not given since it is difficult to interpret or use for comparisons because of variations in the definition of malformation and in completeness of ascertainment in different studies.

Entities:  

Mesh:

Year:  1975        PMID: 123293

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  The prevalence of high insertion of scrotum, hydrocele and mobile testis in the newborn infant (36-42 weeks gestation).

Authors:  J Ben-Ari; P Merlob; F Mimouni; O Rosen; S H Reisner
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

2.  Breech delivery and cryptorchism.

Authors:  C M Beard; K L Noller; L J Melton
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

3.  Respiratory distress and neonatal mortality in infants of diabetic and prediabetic mothers.

Authors:  R D Allen; P J Palumbo
Journal:  Acta Diabetol Lat       Date:  1981 Apr-Jun

4.  Low Rates of Preventive Healthcare Service Utilization Among Adolescents and Adults With Down Syndrome.

Authors:  Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.